StockNews.AI
MDT
StockNews.AI
5 days

Medtronic announces cash dividend for second quarter of fiscal year 2026

1. Medtronic approved a quarterly dividend of $0.71 per share. 2. This is consistent with their dividend increase announced in May 2025. 3. MDT has increased its annual dividend for 48 consecutive years. 4. The dividend payout is on October 17, 2025, for certain shareholders. 5. Medtronic is listed in the S&P 500 Dividend Aristocrats index.

Earnings
+1.13%Current Return
VS
-0.23%S&P 500
$91.9808/14 04:42 PM EDTEvent Start
$93.0208/15 11:10 PM EDTLatest Updated
5m saved
Insight
Article

FAQ

Why Bullish?

MDT's consistent dividend increase highlights financial stability and shareholder return, historically boosting share prices.

How important is it?

The dividend increase showcases MDT's strong financial health, likely attracting more investors.

Why Short Term?

Dividend announcements typically lead to immediate positive market reactions, evident in previous quarterly declarations.

Related Companies

MMMABTSYKPH
, /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 14, 2025, approved the company's cash dividend for the second quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 48 consecutive years. The dividend is payable on October 17, 2025, to shareholders of record at the close of business on September 26, 2025. About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. Contacts:Erika WinkelsPublic Relations+1-763-526-8478 Ryan WeispfenningInvestor Relations+1-763-505-4626 SOURCE Medtronic plc WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News